| |
| |
|
| Insider
Information: |
Grayzel David S. |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
3,891,338 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$59,457,653 |
|
|
| Total
Shares |
3,891,338 |
|
|
| Total
Value |
$59,457,653 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -28.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Surface Oncology, Inc. |
SURF |
Director |
2018-04-23 |
0 |
2023-09-08 |
0 |
Premium* |
|
|
Aerovate Therapeutics, Inc. |
AVTE |
|
2021-07-02 |
0 |
2024-04-09 |
1,799,232 |
Premium* |
|
|
Q32 Bio Inc |
QTTB |
|
|
0 |
2024-03-25 |
2,092,106 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AVTE |
Aerovate Therapeutics, In... |
|
– • – |
2024-04-09 |
4 |
S |
$28.15 |
$334,478 |
I/I |
(11,882) |
14,502 |
0 |
- |
|
| QTTB |
Q32 Bio Inc |
|
– • – |
2024-03-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,092,106 |
|
% |
|
| SURF |
Surface Oncology, Inc. |
Director |
– • – |
2023-09-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,945,453) |
0 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
Director |
– • – |
2021-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
2,568,165 |
2,568,165 |
0 |
- |
|
| AVTE |
Aerovate Therapeutics, In... |
Director |
– • – |
2021-07-02 |
4 |
B |
$14.00 |
$7,499,996 |
I/I |
535,714 |
3,103,879 |
2.1 |
- |
|
| SURF |
Surface Oncology, Inc. |
Director |
– • – |
2020-12-17 |
4 |
S |
$18.10 |
$30,770,000 |
I/I |
(1,700,000) |
2,945,453 |
0 |
% |
|
| SURF |
Surface Oncology, Inc. |
Director |
– • – |
2018-04-23 |
4 |
A |
$0.00 |
$0 |
I/I |
3,181,817 |
4,545,453 |
0 |
- |
|
| SURF |
Surface Oncology, Inc. |
Director |
– • – |
2018-04-23 |
4 |
B |
$15.00 |
$1,500,000 |
I/I |
100,000 |
4,645,453 |
2.1 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
